Lv4
408 积分 2023-12-12 加入
Lonafarnib for chronic hepatitis delta: Clinical mechanism of action, development, and evolving role in combination therapy
14天前
已完结
ALG-020572, an Antisense Oligonucleotide for the Treatment of Chronic Hepatitis B Virus Infection Discontinued for Drug-Induced Liver Injury
16天前
已完结
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells
1个月前
已完结
epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead
1个月前
已完结
Antiviral therapy of hepatitis delta virus infection - progress and challenges towards cure
1个月前
已完结
Hepatitis B
3个月前
已完结
Efficacy and safety of infliximab in patients with autoimmune hepatitis
4个月前
已完结
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
6个月前
已完结
Comparative Efficacy of Treatment Regimens for Chronic Hepatitis D Virus Infection: A Systematic Review and Network Meta-Analysis
6个月前
已完结
Emerging Trends and Future Directions in the Development of Anti-hepatitis B Therapies: A Horizon Scanning Review
6个月前
已完结
皖公网安备34019202002308
